New bile acid blood test to predict risk of stillbirth
[Business Standard, 2/15/19] A simple blood test could be a better way to measure the risk of stillbirth for women with a common liver disorder, say researchers.
The findings, published in The Lancet journal, will help doctors identify the women with intrahepatic cholestasis of pregnancy (ICP) who are at a low risk to carry on their pregnancy normally.
ICP is a liver disorder causing build-up of bile acids in the blood. Pregnant women showing symptoms of ICP are often offered early induction of labour at around 37 weeks in order to prevent stillbirth.
The study showed that the likelihood of stillbirth as a result of ICP is related to the concentration of bile acids in a pregnant woman’s blood, which can be determined by a simple blood test.
Currently, more than 15 per cent of women (at least 18,500 globally) with bile acids below the 100 micromole per litre threshold are delivered early……….
Read the Full Article at: Business Standard
Read more of the web’s hottest women’s health news @ SHEis.com
I would LOVE to hear what you think about this article in the “Leave a Reply” section below. Let’s get the conversion going…
Jaelin Stickels, CNM, WHNP